May 31, 2016
NORDIC NANOVECTOR CAPITAL MARKETS DAY 2016 TO HIGHLIGHT STRONG PROGRESS TOWARDS VISION OF BECOMING A SIGNIFICANT PLAYER IN HAEMATOLOGICAL CANCERS
Media
May 31, 2016
Targovax to present at forthcoming conferences
May 30, 2016
Wilson Therapeutics presents encouraging clinical data on Decuprate® at the Congress of the European Academy of Neurology
May 25, 2016
GenSight Biologics announces the registration of its document de base in relation to its planned IPO on Euronext’s regulated market in Paris
May 23, 2016
NORDIC NANOVECTOR TO HOST CAPITAL MARKETS DAY IN OSLO ON 31 MAY 2016
May 23, 2016
NORDIC NANOVECTOR ASA: NEW BOARD MEMBERS ELECTED BRINGING FURTHER EXPERTISE IN THE DEVELOPMENT AND COMMERCIALIZATION OF INNOVATIVE CANCER THERAPIES
May 19, 2016
NORDIC NANOVECTOR ASA FIRST QUARTER 2016 RESULTS: STRONG PROGRESS ON ALL PRIORITIES AND EXECUTION ON TRACK
May 19, 2016
Wilson Therapeutics AB (PUBL) Interim Report January 1 – March 31, 2016
May 18, 2016
STELVIO Trial Shows Sustained Benefits for Emphysema Patients One Year After Treatment with Zephyr® Endobronchial Valves
May 18, 2016
Nordic Nanovector announces first patient enrolled in the last cohort (Arm 4) of expanded Phase 1/2 study of Betalutin® in NHL patients